Previous studies have shown that PCNA is overexpressed in HCC tissues compared to normal liver tissues, and is associated with aggressive tumor behavior, poor differentiation, and unfavorable clinical outcomes, suggesting that PCNA may be a potential target for the treatment of HCC (Cheng et al., 2020; Shen et al., 2022). This evidence concerns the gene PCNA and neoplasm.